Acer Medical expands AI Healthcare footprint in Thailand: Will showcase 𝗧𝗮𝗶𝘄𝗮𝗻 𝗦𝗺𝗮𝗿𝘁 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 and 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 #WHA79

• • Strengthens Taiwan–Thailand Smart Healthcare through Collaboration with Thai-based New Eye Inc.
  • Acer Medical will participate in the 𝟮𝟬𝟮𝟲 𝗧𝗮𝗶𝘄𝗮𝗻 𝗦𝗺𝗮𝗿𝘁 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 & 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗘𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻 #WHA79

TAIPEI, Taipei — Facing global challenges such as aging population and uneven distribution of healthcare resources, Acer Medical continues to drive clinical adoption of AI-powered solutions has partnered with Upsynergy Taiwan and Thailand-based New Eye Inc., a long-established leader in ophthalmic equipment, to build an integrated healthcare ecosystem in Thailand.

This collaboration combines advanced ophthalmic devices, AI-assisted diagnostic systems (VeriSee), and telemedicine services, injecting new momentum into Thailand’s healthcare system and shaping a cross-border smart healthcare ecosystem.

Dr Allen Lien, chairman and CEO of Acer Medical, stated:

“We are pleased to partner with New Eye and Upsynergy Taiwan to bring Taiwan’s AI healthcare solutions to Thailand. Our focus is to integrate AI into real clinical practice and deliver meaningful impact. Through close collaboration with local partners, we can better address market needs and expand access to smart healthcare.”

Deepening local engagement to advance diverse AI healthcare applications

Acer Medical is actively expanding its presence in Thailand. Its AI-driven ophthalmology solutions—spanning both software and hardware—have already obtained regulatory approval from the Thailand Food and Drug Administration (TFDA), marking a key milestone for market entry. Through strategic collaborations with New Eye and Upsynergy Taiwan, Acer Medical has achieved tangible progress in the Thai market:

• Secured a government-led telemedicine AI healthcare project in Phuket Province across five hospitals, including leading regional hospitals.
• Phuket Provincial Hospital’s adoption of Acer Medical’s ARC-1000 non-mydriatic fundus camera along with VeriSee DR, enhancing care for patients with diabetes through improved screening and monitoring.

Strengthening partnerships to unlock future growth

A delegation from New Eye Inc., recently visited Acer Medical headquarters, led by CEO Somyot Pongsangiam, to engage in in-depth discussions on expanding future collaboration. The partnership aims to introduce innovative smart healthcare solutions to meet Thailand’s growing medical demands.

Somyot Pongsangiam, CEO of New Eye Inc., commented:

 “Taiwan is globally recognised for its strengths in ICT and AI innovation. We value this partnership with Acer Medical and Upsynergy Taiwan, and look forward to expanding into broader and deeper collaboration. Together, we aim to bring more advanced and accessible healthcare solutions to Thailand.”

This collaboration marks another important milestone in Taiwan–Thailand smart healthcare cooperation. Acer Medical will continue to work closely with global partners, leveraging a strategy that integrates technology, local partnerships, and clinical implementation to accelerate the long-term development of AI healthcare worldwide and lead the wave of digital transformation in Southeast Asia.

Acer Medical will participate in the 𝟮𝟬𝟮𝟲 𝗧𝗮𝗶𝘄𝗮𝗻 𝗦𝗺𝗮𝗿𝘁 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 & 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗘𝘅𝗵𝗶𝗯𝗶𝘁𝗶𝗼𝗻. At the 𝗦𝗺𝗮𝗿𝘁 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘇𝗼𝗻𝗲, we will showcase our latest AI-powered medical solutions, including:

• 𝗩𝗲𝗿𝗶𝗦𝗲𝗲 𝘀𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗥- 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗥𝗲𝘁𝗶𝗻𝗼𝗽𝗮𝘁𝗵𝘆, 𝗔𝗠𝗗- 𝗔𝗴𝗲𝗱-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗠𝗮𝗰𝘂𝗹𝗮𝗿 𝗗𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻, 𝗚𝗟𝗖- 𝗚𝗹𝗮𝘂𝗰𝗼𝗺𝗮)
• 𝗩𝗲𝗿𝗶𝗢𝘀𝘁𝗲𝗼 𝗢𝗣 | 𝗳𝗼𝗿 𝗼𝘀𝘁𝗲𝗼𝗽𝗼𝗿𝗼𝘀𝗶𝘀 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗮𝗶𝗚𝗮𝗶𝘁 | 𝗳𝗼𝗿 𝗴𝗮𝗶𝘁 𝗮𝗻𝗱 𝗯𝗮𝗹𝗮𝗻𝗰𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 — covering eye screening, bone health, and mobility evaluation in a comprehensive AI healthcare ecosystem.

This marks 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝘀𝗵𝗼𝘄𝗰𝗮𝘀𝗲 𝗼𝗳 𝗔𝗰𝗲𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹’𝘀 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀. Visit and explore how AI is transforming healthcare: Time: 5/17 (Sun) – 5/19 (Tue) Place: Smart Healthcare Zone, Hotel President Wilson, Geneva, Switzerland. Learn more and register here.